Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | Tanisha, Mehrin Haque |
---|---|
Otros Autores: | Kabir, Eva Rahman |
Formato: | Tesis |
Lenguaje: | English |
Publicado: |
Brac University
2021
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/15533 |
Ejemplares similares
-
CAR-T cell Therapy in B-cell Lymphoma
por: Faruk, Asef
Publicado: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
por: Alam, Kazi Tasnuva
Publicado: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
por: Tania, Umme
Publicado: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
por: Moya, Amena Khatun
Publicado: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
por: Tania, Umme
Publicado: (2021)